# Precigen, Inc.: filings

PGEN · Nasdaq · CIK 1356090 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pgen.md) · [Financials](/companies/pgen/financials.md) · [Filings](/companies/pgen/filings.md) · [Insiders](/companies/pgen/insiders.md)

## Reports and events: 290 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 706, 8-K 184, 3 47, 10-Q 40, 144 21, D 20, 424B5 19, UPLOAD 19, SC 13D/A 18, CORRESP 16, DEFA14A 14, 10-K 13, DEF 14A 13, CT ORDER 10, S-8 10, SC 13G/A 10, 8-K/A 9, 424B7 7, EFFECT 7, ARS 6, D/A 6, 4/A 5, SCHEDULE 13G/A 5, 425 4, FWP 4, S-3 4, SC 13G 4, SCHEDULE 13D/A 4, 10-K/A 3, 10-Q/A 2, 424B3 2, 8-A12B 2, DRS/A 2, PRE 14A 2, S-1/A 2, S-3ASR 2, S-4 2, S-4/A 2, SCHEDULE 13G 2, 144/A 1, 25 1, 305B2 1, 3/A 1, 424B4 1, CERT 1, CERTNYS 1, DRS 1, DRSLTR 1, NT 10-Q 1, S-1 1, S-1MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:08 ET | [10-Q](/filings/0001356090-26-000030.md) | Quarterly report, period 2026-06-30 | 0001356090-26-000030 |
| 2026-08-04 | 16:05 ET | [8-K](/filings/0000950103-26-011876.md) | 2.02 Results of operations | 0000950103-26-011876 |
| 2026-06-24 | 16:07 ET | [8-K](/filings/0000950103-26-009441.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-26-009441 |
| 2026-05-13 | 16:22 ET | [8-K](/filings/0000950103-26-007158.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-26-007158 |
| 2026-05-13 | 16:20 ET | [10-Q](/filings/0001356090-26-000017.md) | Quarterly report, period 2026-03-31 | 0001356090-26-000017 |
| 2026-04-30 | 16:06 ET | [DEF 14A](/filings/0001140361-26-018214.md) | Proxy statement, period 2026-06-18 | 0001140361-26-018214 |
| 2026-03-31 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001213900-26-037403.md) | Ownership report, active investor, amended | 0001213900-26-037403 |
| 2026-03-25 | 16:54 ET | [10-K](/filings/0001356090-26-000009.md) | Annual report, period 2025-12-31 | 0001356090-26-000009 |
| 2026-03-25 | 16:52 ET | [8-K](/filings/0000950103-26-004648.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-26-004648 |
| 2025-11-21 | 20:23 ET | [SCHEDULE 13D/A](/filings/0001213900-25-113780.md) | Ownership report, active investor, amended | 0001213900-25-113780 |
| 2025-11-13 | 16:20 ET | [10-Q](/filings/0001356090-25-000034.md) | Quarterly report, period 2025-09-30 | 0001356090-25-000034 |
| 2025-11-13 | 16:18 ET | [8-K](/filings/0000950103-25-014683.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-25-014683 |
| 2025-09-19 | 20:55 ET | [SCHEDULE 13D/A](/filings/0001213900-25-089729.md) | Ownership report, active investor, amended | 0001213900-25-089729 |
| 2025-09-17 | 16:58 ET | [8-K](/filings/0000950103-25-011775.md) | 3.02 Unregistered sale of equity | 0000950103-25-011775 |
| 2025-09-03 | 07:05 ET | [8-K](/filings/0001104659-25-086669.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-086669 |
| 2025-08-18 | 17:06 ET | [8-K](/filings/0000950103-25-010408.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950103-25-010408 |
| 2025-08-18 | 08:00 ET | [8-K](/filings/0001104659-25-079497.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-079497 |
| 2025-08-12 | 16:29 ET | [10-Q](/filings/0001356090-25-000024.md) | Quarterly report, period 2025-06-30 | 0001356090-25-000024 |
| 2025-06-30 | 16:11 ET | [8-K](/filings/0000950103-25-008124.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-25-008124 |
| 2025-05-16 | 16:03 ET | [DEF 14A](/filings/0001140361-25-019470.md) | Proxy statement, period 2025-06-26 | 0001140361-25-019470 |
| 2025-05-14 | 16:23 ET | [10-Q](/filings/0001356090-25-000019.md) | Quarterly report, period 2025-03-31 | 0001356090-25-000019 |
| 2025-05-14 | 16:19 ET | [8-K](/filings/0000950103-25-006004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-25-006004 |
| 2025-04-28 | 17:23 ET | [10-K/A](/filings/0001356090-25-000011.md) | Annual report, amended, period 2024-12-31 | 0001356090-25-000011 |
| 2025-03-19 | 16:30 ET | [10-K](/filings/0001356090-25-000007.md) | Annual report, period 2024-12-31 | 0001356090-25-000007 |
| 2025-03-19 | 16:22 ET | [8-K](/filings/0000950103-25-003637.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-25-003637 |
| 2025-01-16 | 16:07 ET | [8-K](/filings/0000950103-25-000576.md) | 8.01 Other events | 0000950103-25-000576 |
| 2024-12-30 | 19:29 ET | [SCHEDULE 13D/A](/filings/0001213900-24-113602.md) | Ownership report, active investor, amended | 0001213900-24-113602 |
| 2024-12-30 | 16:18 ET | [8-K](/filings/0000950103-24-018479.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-018479 |
| 2024-12-26 | 16:40 ET | [8-K](/filings/0000950103-24-018350.md) | 1.01 Entry into a material agreement | 0000950103-24-018350 |
| 2024-11-14 | 16:52 ET | [10-Q](/filings/0001356090-24-000026.md) | Quarterly report, period 2024-09-30 | 0001356090-24-000026 |
| 2024-11-14 | 16:47 ET | [8-K](/filings/0000950103-24-016317.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-016317 |
| 2024-11-07 | 16:05 ET | [8-K](/filings/0000950103-24-016076.md) | 3.01 Delisting notice | 0000950103-24-016076 |
| 2024-10-10 | 16:33 ET | [8-K](/filings/0000950103-24-014811.md) | 1.02 Termination of a material agreement | 0000950103-24-014811 |
| 2024-09-23 | 19:44 ET | [8-K](/filings/0000950103-24-013816.md) | 5.02 Departure or appointment of officers or directors | 0000950103-24-013816 |
| 2024-08-30 | 17:00 ET | [8-K](/filings/0000950103-24-012981.md) | 5.02 Departure or appointment of officers or directors | 0000950103-24-012981 |
| 2024-08-14 | 16:25 ET | [10-Q](/filings/0001356090-24-000017.md) | Quarterly report, period 2024-06-30 | 0001356090-24-000017 |
| 2024-08-14 | 16:19 ET | [8-K](/filings/0000950103-24-012201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-012201 |
| 2024-08-13 | 16:05 ET | [SC 13D/A](/filings/0001213900-24-068241.md) | Ownership report, active investor, amended | 0001213900-24-068241 |
| 2024-08-09 | 09:04 ET | [8-K](/filings/0001104659-24-087596.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-087596 |
| 2024-08-06 | 16:13 ET | [8-K](/filings/0001104659-24-086275.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-086275 |
| 2024-07-05 | 17:16 ET | [8-K](/filings/0000950103-24-009693.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-24-009693 |
| 2024-05-28 | 16:44 ET | [DEF 14A](/filings/0001104659-24-065631.md) | Proxy statement, period 2024-07-05 | 0001104659-24-065631 |
| 2024-05-14 | 17:23 ET | [10-Q](/filings/0001356090-24-000010.md) | Quarterly report, period 2024-03-31 | 0001356090-24-000010 |
| 2024-05-14 | 17:19 ET | [8-K](/filings/0000950103-24-006675.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-006675 |
| 2024-05-03 | 20:01 ET | [SC 13D/A](/filings/0001213900-24-039858.md) | Ownership report, active investor, amended | 0001213900-24-039858 |
| 2024-04-29 | 16:05 ET | [10-K/A](/filings/0001104659-24-054003.md) | Annual report, amended, period 2023-12-31 | 0001104659-24-054003 |
| 2024-03-19 | 16:48 ET | [10-K](/filings/0001356090-24-000007.md) | Annual report, period 2023-12-31 | 0001356090-24-000007 |
| 2024-03-19 | 16:17 ET | [8-K](/filings/0000950103-24-004017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-004017 |
| 2024-02-08 | 16:25 ET | [8-K](/filings/0000950103-24-001932.md) | 5.02 Departure or appointment of officers or directors | 0000950103-24-001932 |
| 2024-01-08 | 08:39 ET | [8-K](/filings/0000950103-24-000379.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-24-000379 |

Page 1 of 6. [Older](/companies/pgen/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.